Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$5.77 - $9.82 $201,765 - $343,385
34,968 New
34,968 $221,000
Q4 2023

Feb 13, 2024

BUY
$7.89 - $13.14 $186,527 - $310,642
23,641 New
23,641 $301,000
Q3 2021

Nov 12, 2021

SELL
$35.98 - $44.48 $223,363 - $276,131
-6,208 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$37.61 - $48.0 $233,482 - $297,984
6,208 New
6,208 $274,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.